Charles River Laboratories International

North America, Massachusetts, United States, Wilmington

Description

Charles River Laboratories International is a pharmaceutical company that offers laboratory products and services for drug discovery.

Investor Profile

Charles River Laboratories International has made 12 investments, with 2 in the past 12 months and 17% as lead.

Stage Focus

Series A (33%)
Series B (25%)
Seed (17%)
Series Unknown (17%)
Series C (8%)

Country Focus

United States (42%)
Canada (17%)
France (17%)
Ireland (17%)
United Kingdom (8%)

Industry Focus

Biotechnology
Life Science
Medical
Therapeutics
Health Care
Artificial Intelligence (Ai)
Health Diagnostics
Software
Manufacturing
Commercial

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Charles River Laboratories International frequently co-invest with?

Fonds de solidarité FTQ

North America, Quebec, Canada, Montréal

Co-Investments: 2

Fraser

Europe, England, United Kingdom, London

Co-Investments: 2

Amplitude Venture Capital

North America, Quebec, Canada, Montréal

Co-Investments: 2

Alexandria Venture Investments

North America, California, United States, Pasadena

Co-Investments: 2

ATUM

North America, California, United States, Newark

Co-Investments: 2

Ampersand Capital Partners

North America, Massachusetts, United States, Wellesley

Co-Investments: 2

Verve Ventures

Europe, Zug, Switzerland, Zug

Co-Investments: 2

Kurma Partners

Europe, Ile-de-France, France, Paris

Co-Investments: 2

Dynamk Capital

North America, New York, United States, New York

Co-Investments: 2

Alloy Therapeutics

North America, Massachusetts, United States, Waltham

Co-Investments: 2

Which angels does Charles River Laboratories International often collaborate with?

Milad Alucozai

North America, California, United States, San Francisco

Shared Deals: 1

What are some of recent deals done by Charles River Laboratories International?

Deciphex

Glasnevin, Dublin, Ireland

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

Artificial Intelligence (AI)Health DiagnosticsSoftware

Series CJan 7, 2025

Amount Raised: $32,202,774

Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science

SeedJun 18, 2024

Amount Raised: $6,000,000

Ability biologics

Ville-marie, Quebec, Canada

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

BiotechnologyLife Science

SeedDec 6, 2023

Amount Raised: $12,000,000

Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical

Series AJun 27, 2023

Amount Raised: $20,000,000

iVexSol

Lexington, Massachusetts, United States

IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.

Manufacturing

Series AJan 26, 2023

Amount Raised: $23,800,000

Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics

Series AOct 4, 2022

Amount Raised: $31,000,000

Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical

Series AJun 2, 2022

Amount Raised: $21,000,000

Deciphex

Dublin, Dublin, Ireland

Deciphex uses digital pathology and AI to address the pathology productivity gap

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsSoftware

Series BMay 19, 2022

Amount Raised: $11,500,000

PathoQuest

Paris, Ile-de-France, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

BiotechnologyHealth CareTherapeutics

Series BNov 9, 2021

Amount Raised: $17,391,748

bit.bio

Cambridge, Cambridgeshire, United Kingdom

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

BiotechnologyCommercialHealth Care

Series BNov 5, 2021

Amount Raised: $103,000,000

Charles River Laboratories International

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Charles River Laboratories International frequently co-invest with?

Which angels does Charles River Laboratories International often collaborate with?

What are some of recent deals done by Charles River Laboratories International?

Ready to Raise Capital?

Pages

Free tools